Expert Commentary

Ideal patient selection for this new approach to HT

A peer-to-peer audiocast with JoAnn Pinkerton, MD, and Anne Moore, DNP, APN


 

Dr. Moore and Dr. Pinkerton focus on a new estrogen therapy: the combination conjugated estrogen and bazedoxifene (CE/BZA) for the treatment of moderate to severe hot flashes due to menopause and the prevention of menopausal osteoporosis.

Which patients can benefit most? What is CE/BZA’s safety profile? How do traditional estrogen-progestin therapies compare with CE/BZA therapy? Tune in for answers to these questions and more.

Read Cases in Menopause: Conjugated estrogen plus bazedoxifene —a new approach to estrogen therapy, from Dr. Anne Moore and Dr. JoAnn Pinkerton (October 2014).

Next Article:

New mobile app assists clinicians in assessing menopausal patients

Related Articles